We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OKE:NYSEONEOK, Inc. Analysis

Data as of 2026-03-10 - not real-time

$85.96

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

ONEOK is trading at $85.96, comfortably above its 20‑day SMA of $85.11 and 50‑day SMA of $79.38, indicating a short‑term bullish bias. The RSI sits at 58, suggesting room for upside without being overbought, while the MACD histogram is slightly negative, hinting at a modest pull‑back before the trend resumes. Volume is increasing, and the price is holding above the key support level of $79.73 with resistance near $89, framing a clear upside corridor. Fundamentally, the stock appears undervalued with a trailing PE of 15.9 versus the industry average of 20.6, and a forward PE of 14.3, while delivering a generous 4.84% dividend yield. Recent analyst sentiment is positive, highlighted by Stifel’s reaffirmed buy rating and a $5 increase in price targets following the latest earnings beat, reinforcing the upside potential toward the consensus target of $89.65.
However, the balance sheet shows a high debt‑to‑equity ratio of 146 and a payout ratio of 76%, raising questions about long‑term dividend sustainability. The stock’s beta of 0.86 and 30‑day volatility of 32% suggest moderate market sensitivity, but the regulated midstream business model provides a defensive cushion. Overall, the mix of technical strength, attractive valuation, and solid cash flow supports a buy recommendation for the near to medium term, while monitoring debt levels and dividend coverage for the long haul.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above 20‑day and 50‑day SMAs
  • Increasing volume trend
  • Support level intact with upside to $89 resistance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued PE relative to industry
  • Strong revenue growth (≈30%) and positive free cash flow
  • High dividend yield with recent analyst upgrades

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Regulated cash‑flow stability
  • Elevated debt‑to‑equity ratio
  • Potential dividend sustainability concerns

Key Metrics & Analysis

Financial Health

Revenue Growth29.50%
Profit Margin10.09%
P/E Ratio15.9
ROE15.49%
ROA5.57%
Debt/Equity146.45
P/B Ratio2.4
Op. Cash Flow$5.6B
Free Cash Flow$725.4M
Industry P/E20.6

Technical Analysis

TrendBullish
RSI58.5
Support$79.73
Resistance$89.00
MA 20$85.11
MA 50$79.38
MA 200$76.19
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Target Price$89.65
Upside/Downside4.29%
GradeUndervalued
TypeBlend
Dividend Yield4.84%

Risk Assessment

Beta0.86
Volatility32.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.